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1. Intrinsic immunological differences between animals and humans result in poor 
translation of vaccine responses from animal models to the human setting. Hence, 
alternative approaches that can help increase the odds of vaccines in succeeding in 
clinical trials are urgently needed. 
2. Genomics and systems biology have fuelled advances in our understanding of 
human immunology. Together with adjuvant development and structure-based 
design of immunogens, these next-generation technologies are transforming the 
field of vaccinology and shaping the future of medicine.
3. Primary cells, irrespective whether they are derived from fresh or frozen PBMCs 
are a robust and reproducible platform to assess the immunogenicity of vaccine 
candidates and vaccine-induced immune mechanisms. (This thesis) 
4. Human primary Mo-DCs and T cells are capable of responding to vaccines in 
measurable and consistent ways even if the vaccines are inactivated and non-
adjuvanted. (This thesis) 
5. An in vitro platform using long-term cultures of PBMCs is suitable to identify 
distinctive responses of human T cells, including T follicular helper cells to vaccines 
and vaccine candidates. (This thesis) 
6.  An in vitro vaccine evaluation system, which focusses on innate (DCs) and adaptive 
(T cells) responses could potentially serve four purposes: assess the quality of vaccines 
batches, select promising vaccine candidates, reveal vaccine mechanisms and help 
identifying ways to improve protective responses. (This thesis) 
7. “Productivity is for robots. Humans excel at wasting time, experimenting, playing, 
creating, and exploring.” – Kevin Kelly 
8. “In preparing for battle, I have found that planning is essential, but plans are useless.” 
– Dwight D. Eisenhower
9. “Cultural and religious stereotypes are useless for understanding the world.” – Hans 
Rosling, Factfulness
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